Clinical Trial Update: Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating the safety and immune response of an HIV vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED